Suchergebnisse - "McDonald, Kerrie L"

PubPharm (5)

1

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma : the VERTU study

enthalten in: Neuro-oncology | 2021

von Sim, H. | McDonald, K. | Lwin, Z. | +15

2

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)

enthalten in: Scientific reports | 2019

von Ha, W. | Sevim-Nalkiran, H. | Zaman, A. | +6

3

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma

enthalten in: Journal of translational medicine | 2017

von Jue, T. | Nozue, K. | Lester, A. | +7

4

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

enthalten in: Neuro-oncology | 2015

von Rapkins, R. | Wang, F. | Nguyen, H. | +6

5

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

enthalten in: Journal of neuro-oncology | 2008

von Parkinson, J. | Wheeler, H. | Clarkson, A. | +7

1
[1]